In the context of Russia's war against Ukraine, the media has an important role to play in reporting the truth and spreading the message to the world about the aggression against our brothers and sisters in Ukraine.

The Creativity and Innovation Center "LinkMenų fabrikas" of Vilnius Gediminas Technical University (VILNIUS TECH) is contributing to the publicity of the situation by handing over the hangar of VILNIUS TECH's "LinkMenų Fabrikas" to a visiting ternational television and radio BBC film crew. On Monday 7, March, 7 pm., VILNIUS TECH "LinkMenų Fabrikas" will host the BBC's debate programme"BBC Global Questions".

This episode will welcome panellists who will take your questions on Lithuania, Estonia and Latvia – where people are wondering whether they could be the next target for President Putin. Would he ever dare attack a NATO member? And has his invasion of Ukraine merely strengthened the alliance, and encouraged neutral states like Sweden and Finland to consider joining the alliance?

All audiences members will be invited to submit their questions and a selection will be made ahead of the recording.

Global Questions is the BBC’s international TV and radio debate programme that gives you the chance to put your questions to a high-profile panel of decision makers and influencers. Hosted by the award-winning journalist and presenter Zeinab Badawi Global Questions travels around the world handing the microphone to the audience and tackling big topics.

The programme is broadcast around the world on BBC World News, BBC World Service Radio and in the UK on the BBC News Channel.

VILNIUS TECH LinkMenų fabrikas will donate all the money received for the organization of the event to the fund established by the university for Ukrainian students.

Participation in the event is free.

More information about filming the episode can be found here.

COVID-19 information.
This programme will be recorded outside with a socially distanced audience in line with local Covid protocols. All audience members must show proof of vaccination against Covid-19.